Crossmab by Creative Biolabs

bellasmithPublished: December 25, 2017
Published: December 25, 2017

Recombinant Anti-CC531 × Anti-CD8 Bispecific Antibody (CrossMab) has been generated by applying the Crossmab format to generate an IgG shaped entity that binds each ligand with one arm. It was designed for the treatment of Colon carcinoma.

http://www.creativebiolabs.net/Bispecific-CC531-CD8-CrossMab-20180.htm

Recommend tags
  • science+1
  • biology+1

sciencebiology

Comments

0 comments